A critical breakthrough in cancer research is occurring with the use of VHH fragments to re-engage mutated p53. This crucial cancer inhibitor protein is frequently disabled in many kinds of malignancies, causing https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research